Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments.
Ontology highlight
ABSTRACT: Peptide-based nanomaterials can serve as promising drug delivery agents, facilitating the release of active pharmaceutical ingredients while reducing the risk of adverse reactions. We previously demonstrated that Cyclo-Histidine-Histidine (Cyclo-HH), co-assembled with cancer drug Epirubicin, zinc, and nitrate ions, can constitute an attractive drug delivery system, combining drug self-encapsulation, enhanced fluorescence, and the ability to transport the drug into cells. Here, we investigated both computationally and experimentally whether Cyclo-HH could co-assemble, in the presence of zinc and nitrate ions, with other cancer drugs with different physicochemical properties. Our studies indicated that Methotrexate, in addition to Epirubicin and its epimer Doxorubicin, and to a lesser extent
SUBMITTER: Vlachou A
PROVIDER: S-EPMC11022239 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA